The existing authors executed an open-label pilot analyze that administered psilocybin to 15 cure-resistant tobacco/nicotine-dependent smokers, inside the context of cognitive behavioral therapy for using tobacco cessation [fifty eight]. Contributors were administered ~0.29 mg/kg oral psilocybin around the participant’s focus on day to quit using